Cardiopulmonary bypass (CPB) stands as a crucial medical intervention utilized during cardiac surgeries, temporarily assuming the vital functions of the heart and lungs. This intricate procedure involves rerouting the patient's blood away from the heart and lungs, employing a heart-lung machine to take charge of oxygenation and blood circulation throughout the body. Acting as a surrogate for natural physiological processes, the machine effectively removes carbon dioxide and adds oxygen to the blood. By inducing a state of motionlessness and bloodlessness in the heart, CPB enables surgeons to conduct intricate cardiac procedures that would otherwise be challenging or impractical. While integral to various cardiac interventions, the application of cardiopulmonary bypass comes with inherent risks. Ongoing research is dedicated to refining CPB techniques to minimize potential complications, ensuring improved patient outcomes. The evolution of this technology has significantly propelled the field of cardiac surgery, revolutionizing the landscape of life-saving interventions and enhancing the overall success of complex cardiac procedures.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States